In our experiments, the influence of the p53 status of the HPV-negative HNSCC cell lines on the radiosensitizing capabilities of PARPis was not great enough to be noticeable among the effects of various other differences between the cell lines that may influence treatment effectiveness, and it does not explain the heterogeneity found. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.